Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression.

The expression of the prion (PRNP) and prion like-doppel (PRND) genes and the presence of the proteins prion (PrP) and doppel (Dpl) were investigated in human gliomas. The PRNP and PRND expression profiles were evaluated by real-time reverse transcription-quantitative PCR in low- and high-grade astrocytomas, in glioblastoma-derived cell lines and in non-glial tumor specimens. The presence of PrP and Dpl proteins and their cellular localization were evaluated by Western blot and immunohistochemistry. High levels of PRNP expression were found in all tumoral samples studied. Unlike the non-tumoral controls, PRND was aberrantly expressed in glioblastoma multiforme and in two glioblastoma multiforme-derived cell lines, even in the absence of the PRND gene amplification. PRND expression was directly related to malignancy of the tumor: highest in glioblastoma multiforme, lower in anaplastic astrocytoma and even lower in the low-grade astrocytoma samples. High levels of PRND were also found in non-glial malignant tumor samples, such as gastric adenocarcinoma and anaplastic meningioma. Western blot analysis confirmed the PrP and Dpl expression, displaying variability in the electrophoretic patterns. Immunohistochemical analysis revealed a diffuse cytoplasmatic Dpl distribution in different astrocytic neoplastic cells, in infiltrating lymphocytes and in blood vessel endothelial cells. Of note, Dpl reactivity was different from that of the PrP, since PrP showed typical Golgi and membrane localised staining. Our findings suggest that the PRND gene might be a useful molecular marker in astrocytoma progression and in tumor grade definition. Understanding of the mechanisms of PRND increased expression might provide insight into the regulatory pathways of glioma development.

[1]  R. Riek,et al.  NMR structure of the human doppel protein. , 2003, Journal of molecular biology.

[2]  J. Laplanche,et al.  Prion‐like protein Doppel expression is not modified in scrapie‐infected cells and in the brains of patients with Creutzfeldt–Jakob disease , 2003, FEBS letters.

[3]  J. Collinge,et al.  Genomic characterization of the human prion protein (PrP) gene locus , 2002, Mammalian Genome.

[4]  J. Laplanche,et al.  The Human “Prion-like” Protein Doppel Is Expressed in Both Sertoli Cells and Spermatozoa* , 2002, The Journal of Biological Chemistry.

[5]  Y. Shaked,et al.  Doppel and PrPC do not share the same membrane microenvironment , 2002, FEBS letters.

[6]  F. Heppner,et al.  Absence of the prion protein homologue Doppel causes male sterility , 2002, The EMBO journal.

[7]  J. Sawada,et al.  G1-dependent prion protein expression in human glioblastoma cell line T98G. , 2002, Biological & pharmaceutical bulletin.

[8]  W. Paulus,et al.  L1 expressed by glioma cells promotes adhesion but not migration , 2002, Glia.

[9]  Janka Held‐Feindt,et al.  CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors , 2002, International journal of cancer.

[10]  A. Aguzzi,et al.  Small is not beautiful: antagonizing functions for the prion protein PrPC and its homologue Dpl , 2002, Trends in Neurosciences.

[11]  Wei Zhang,et al.  Molecular Classification of Human Diffuse Gliomas by Multidimensional Scaling Analysis of Gene Expression Profiles Parallels Morphology‐Based Classification, Correlates with Survival, and Reveals Clinically‐Relevant Novel Glioma Subsets , 2002, Brain pathology.

[12]  S. Lindquist,et al.  Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Richard C. Moore,et al.  Doppel-induced cerebellar degeneration in transgenic mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[15]  D. Westaway,et al.  The prion gene complex encoding PrP(C) and Doppel: insights from mutational analysis. , 2001, Gene.

[16]  D. Louis,et al.  Glioma classification: a molecular reappraisal. , 2001, The American journal of pathology.

[17]  H. Axelrad,et al.  Cellular and subcellular morphological localization of normal prion protein in rodent cerebellum , 2001, The European journal of neuroscience.

[18]  David E. Misek,et al.  The gene for the axonal cell adhesion molecule TAX-1 is amplified and aberrantly expressed in malignant gliomas. , 2001, Cancer research.

[19]  N. M. Khazenzon,et al.  Gene expression abnormalities in human glial tumors identified by gene array. , 2001, International journal of oncology.

[20]  Eric C. Holland,et al.  Gliomagenesis: genetic alterations and mouse models , 2001, Nature Reviews Genetics.

[21]  A. Li,et al.  Physiological expression of the gene for PrP-like protein, PrPLP/Dpl, by brain endothelial cells and its ectopic expression in neurons of PrP-deficient mice ataxic due to Purkinje cell degeneration. , 2000, The American journal of pathology.

[22]  M. Sy,et al.  Expression and structural characterization of the recombinant human doppel protein. , 2000, Biochemistry.

[23]  V. Jung,et al.  Comparative genomic hybridization reveals recurrent enhancements on chromosome 20 and in one case combined amplification sites on 15q24q26 and 20p11p12 in glioblastomas. , 2000, Cancer genetics and cytogenetics.

[24]  F. Cohen,et al.  Doppel is an N-glycosylated, glycosylphosphatidylinositol-anchored protein. Expression in testis and ectopic production in the brains of Prnp(0/0) mice predisposed to Purkinje cell loss. , 2000, The Journal of biological chemistry.

[25]  J. Laplanche,et al.  First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases , 2000, Neuroscience Letters.

[26]  Inyoul Y. Lee,et al.  Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. , 1999, Journal of molecular biology.

[27]  Y Sawamura,et al.  Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. , 1999, Neuro-oncology.

[28]  S. Comincini,et al.  Comparative mapping of the prion gene (PRNP) locus in cattle, sheep and human with PCR-generated probes , 1998, Mammalian Genome.

[29]  S. Hakomori.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.

[30]  M. Pignatelli,et al.  Adhesion molecules: novel molecular tools in tumor pathology. , 1994, Human pathology.

[31]  G. Pilkington.  Tumour Cell Migration in the Central Nervous System , 1994, Brain pathology.

[32]  R. McLendon,et al.  Alterations of the TP53 gene in human gliomas. , 1994, Cancer research.

[33]  G. Mazzini,et al.  Establishment and characterization of two cell lines derived from human glioblastoma multiforme. , 1992, Anticancer research.

[34]  P. Walker,et al.  Immune escape of gliomas. , 2001, Progress in brain research.

[35]  S. Comincini.  Searching for molecular markers of human gliomas. , 2001, Functional neurology.

[36]  J. Fournier,et al.  Nonneuronal cellular prion protein. , 2001, International review of cytology.

[37]  H. Budka,et al.  An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors. , 1986, Clinical neuropathology.